Saturday, October 31, 2026

Boston Beer Company Stock Bearish By 17% In The Last 5 Sessions

ViaNews Editorial Team

February 21, 2023

Boston Beer Company Stock Bearish By 17% In The Last 5 Sessions

(VIANEWS) - Shares of Boston Beer Company (NYSE: SAM) slid by a staggering 17.42% in 5 sessions from $393.11 to $324.63 at 12:55 EST on Tuesday, after four sequential sessions in a row of losses. NYSE is sliding 1.37% to $15,622.37, after four consecutive sessions in a row of losses.

Boston Beer Company's last close was $329.04, 22.17% under its 52-week high of $422.75.

About Boston Beer Company

The Boston Beer Company, Inc. produces and sells alcohol beverages primarily in the United States. The company's flagship beer is Samuel Adams Boston Lager. It offers various beers, hard ciders, and hard seltzers under the Samuel Adams, Twisted Tea, Truly Hard Seltzer, Angry Orchard, Dogfish Head, Angel City, Coney Island, Concrete Beach brand names. The company markets and sells its products to a network of approximately 400 wholesalers in the United States, as well as international wholesalers, importers, or other agencies that in turn sell to retailers, such as grocery stores, club stores, convenience stores, liquor stores, bars, restaurants, stadiums, and other retail outlets. It also sells in products in Canada, Europe, Israel, Australia, New Zealand, the Caribbean, the Pacific Rim, Mexico, and Central and South America. The Boston Beer Company, Inc. was founded in 1984 and is based in Boston, Massachusetts.

Earnings Per Share

As for profitability, Boston Beer Company has a trailing twelve months EPS of $19.29.

PE Ratio

Boston Beer Company has a trailing twelve months price to earnings ratio of 16.83. Meaning, the purchaser of the share is investing $16.83 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.56%.

Growth Estimates Quarters

The company's growth estimates for the current quarter and the next is 118.5% and 756.2%, respectively.

Yearly Top and Bottom Value

Boston Beer Company's stock is valued at $324.63 at 12:55 EST, way below its 52-week high of $422.75 and way higher than its 52-week low of $287.00.

Sales Growth

Boston Beer Company's sales growth is 13.1% for the current quarter and 6.4% for the next.

More news about Boston Beer Company (SAM).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com